Reta

Triple receptor agonist — simultaneously activates GLP-1, GIP, and glucagon receptors — the first compound to target all three. Clinical data show up to 24 % weight loss after 48 weeks and reduction of liver fat by over 82 %, placing Retatrutide among the most effective for obesity and metabolic disorders.

For research use only.